HEMGENIX - AN OVERVIEW

Range of suitable sufferers: CDEC talked over the uncertainty in the amount of individuals with reasonably severe to severe hemophilia B in Canada suitable for etranacogene dezaparvovec. Clinical professionals consulted by CADTH indicated that some patients that are classified as acquiring gentle or moderate condition could have a serious bleeding